Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X

Vincent Muczynski1, Amine Bazaa1, Cécile Loubière1

  • 1Unité 1176 INSERM, Le Kremlin-Bicêtre, France; and Unité Mixte de Recherche S1176, Université Paris-Sud, Le Kremlin-Bicêtre, France.

Blood
|November 27, 2015
PubMed

Insights

Macrophages regulate coagulation factor X (FX) levels through scavenger receptor type A member I (SR-AI). This interaction, specific to macrophages, impacts FX

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Coagulation Factor X (FX) plays roles beyond coagulation, including in inflammation and immune responses.
  • FX's long circulatory half-life is associated with its interaction with liver-resident macrophages.
  • This interaction is specific to differentiated macrophages, not monocytes.

Purpose of the Study:

  • To identify the specific receptor on macrophages responsible for interacting with FX.
  • To elucidate the mechanism by which macrophages regulate FX plasma levels.

Main Methods:

  • Cell biology techniques using primary and THP1-derived macrophages.
  • Studies with transfected cells and scavenger receptor type A member I (SR-AI)-deficient mice.
  • Protein binding assays to quantify FX and SR-AI interaction.

Main Results:

  • Scavenger receptor type A member I (SR-AI) was identified as a macrophage-specific receptor for FX.
  • SR-AI-deficient mice showed reduced circulating FX levels and impaired FX-macrophage interaction.
  • FX specifically binds to the extracellular domain of SR-AI with a half-maximal binding concentration of 3 μg/mL.

Conclusions:

  • Macrophages regulate FX plasma levels in an SR-AI-dependent manner.
  • SR-AI is crucial for FX-macrophage interactions and influences FX circulatory levels.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.3K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K